Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency.
about
Toward a therapy for mitochondrial diseaseHeart mitochondrial TTP synthesis and the compartmentalization of TMP.MPV17 Loss Causes Deoxynucleotide Insufficiency and Slow DNA Replication in MitochondriaMitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies.GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction.Emerging therapies for mitochondrial disorders.Mutations causing mitochondrial disease: What is new and what challenges remain?Mitochondrial purine and pyrimidine metabolism and beyond.MtDNA-maintenance defects: syndromes and genes.DGUOK recessive mutations in patients with CPEO, mitochondrial myopathy, parkinsonism and mtDNA deletions.Deoxycytidine and Deoxythymidine Treatment for Thymidine Kinase 2 Deficiency.Author's Reply: TK2-related Myopathic Mitochondrial Depletion Syndrome.Low-dose rapamycin extends lifespan in a mouse model of mtDNA depletion syndrome.Retrospective natural history of thymidine kinase 2 deficiency.Clinical Reasoning: A 58-year-old man with progressive ptosis and walking difficulty.Towards a therapy for mitochondrial disease: an update
P2860
Q28080024-49949673-9C49-469C-B12D-F4722BFD064BQ35002808-4D7F8FF8-1025-4C95-AB6F-D80C92DA6608Q35892524-4C8A7B3D-B34F-491C-AF1E-62F601E8C1D0Q35893619-EA7DA3E8-16FA-43D0-B876-34C0568B29D2Q35920919-8F62B011-E1EF-4D94-AFA4-D91766A525AEQ36967723-E4C27B35-6570-4283-9A01-BD9AD977C559Q38592664-45305B99-4F35-4B50-9AF3-8ECCE3FAB26AQ39025697-E1AE3F82-5150-434D-AA1D-CF529E47DE3EQ40955181-C5601D98-CDE7-47E4-974C-94405CCAEB19Q47922275-83C122E8-F1D3-4461-97C3-C30215DC6B23Q47945459-8D137DDC-9D98-4EC9-A7EF-EF3785490F64Q49663982-A650BBE8-A074-49BE-8316-85846439D466Q50426370-2EE5E79D-A8E5-4758-A0A8-8828D3E7E8BAQ54981490-40293337-C437-475F-8494-81E0D5E2CA6BQ55407764-0EA4C118-5A63-47FF-88FB-76DF7773FE39Q57293416-3BC090E5-5F37-44DA-B9E9-7E17E89BF866
P2860
Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency.
@ast
Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency.
@en
Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency.
@nl
type
label
Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency.
@ast
Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency.
@en
Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency.
@nl
prefLabel
Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency.
@ast
Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency.
@en
Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency.
@nl
P2093
P2860
P50
P356
P1476
Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency
@en
P2093
Catarina M Quinzii
Hasan O Akman
Kurenai Tanji
Michio Hirano
Saba Tadesse
Valentina Emmanuele
P2860
P304
P356
10.15252/EMMM.201404092
P577
2014-08-01T00:00:00Z